To validate the elevated Wee1 and CDK1 expression of EGFRvIII+ cells in human GBM, we analyzed primary patient tissue, using GBM samples displaying typical heterogeneous EGFRvIII expression. The gene discussed is WEE1; the disease is glioblastoma.